Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 10-1996 | |
| Gross Profit | N/A | N/A | N/A | N/A | 52,225 |
| Operating Expenses | 3,833 | 882 | 0 | 0 | 5,455 |
| Operating Income | -3,833 | -882 | N/A | N/A | -5,455 |
| Interest Expense | 26 | 29 | 0 | 0 | 0 |
| Other Income | -18 | -6,482 | 0 | 0 | 0 |
| Pre-tax Income | -3,877 | -7,392 | 0 | 0 | -5,455 |
| Net Income Continuous | -3,877 | -7,392 | N/A | N/A | -5,455 |
| Net Income | $-3,877 | $-7,392 | $N/A | $N/A | $-5,455 |
| EPS Basic Total Ops | -25,212.61 | -63,031.51 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -25,580.57 | -63,324.49 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -25,212.61 | -63,031.51 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -25,580.57 | -63,324.49 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -25,212.60 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-3,813 | $-864 | $N/A | $N/A | $-724 |